Macquarie Group
BNR

Macquarie Group’s Burning Rock Biotech BNR Stock Holding History

Macquarie Group’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-322
Closed -$58K – 2606
2021
Q3 		$58K Hold
322
– – ﹤0.01% 2180
2021
Q2 		$95K Buy
+322
New +$95.3K ﹤0.01% 1982

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group's BNR Position: Q4 2021 in Review

Macquarie Group sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 322 shares — an estimated $58K sold.

Macquarie Group first reported a position in BNR in Q2 2021 and held it in 2 quarters. The position peaked at $95K in Q2 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • Macquarie Group reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • Macquarie Group sold 322 Burning Rock Biotech shares in Q4 2021, an estimated $58K.
  • Macquarie Group first reported a position in Burning Rock Biotech in Q2 2021 and held it in 2 quarters.
  • Macquarie Group's Burning Rock Biotech position peaked at $95K in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.